Health Strategies Insights

Deepest insights on your most pressing market access needs

Health Strategies Insights by EVERSANA gives you an advanced set of capabilities, frameworks, and methods. These are all derived from a robust stakeholder panel, providing critical answers to your specific payer marketing and market access questions.

Product Portfolio

  • Market Access

    Monitors and evaluates U.S. market access trends to anticipate environment shifts that affect access and reimbursement

    Learn More
  • Brand Access

    Identifies current and future opportunities to optimize access for your brands

    Learn More
  • Account Access

    Guides account strategies to impact sales and marketing at leading organizations

    Learn More
  • Patient Access

    Assesses and measures key opportunities to improve satisfaction and patient access to therapies

    Learn More


Advanced Market Access Knowledge Answers Your Specific Questions

Our thought-leading experts just launched our new, groundbreaking intelligence platform, INTELLICENTER. This platform gives you a data-driven, evergreen, advanced set of market access knowledge, trends to provide critical answers to your specific market access questions.

  • Anticipate how the macro environment and future trends will affect access
  • Identify current and future opportunities and risks for your brand
  • Develop or adjust access strategies for your brand
  • Build programs that optimize your brand’s access
  • Benchmark your team’s performance against competitors on the competencies and attributes that lead to stronger MCO and IDN customer relationships

Whether you would like to download your information in Powerpoint, Excel, or even Raw Data Tables, our easy to use, dynamic portal gives you what you need when you need it.



Be curious. Discover the unexpected.

ACCESSEXPRESS gives you the power to think without restraint, gain fresh insights, and learn from unanticipated perspectives.

We give you access to an unrivaled expert network of market access stakeholders. With 100% of the leading health plans and pharmacy benefit managers (PBMs), the top 100 hospital systems, and the top 200 oncology centers in the US, you can have the utmost confidence in your results.

  • Health Plans. Over 4,000 medical and pharmacy executives who are decision makers from regional, national, and Blues health plans
  • PBMs. Over 500 pharmacy, contracting, medical, and executive decision makers at the leading PBMs
  • Hospital Systems. Over 2,900 medical and pharmacy executives who are decision makers in the leading hospital systems
  • Oncology Centers. Over 1,600 medical and pharmacy executives who are decision makers from influential oncology centers including stand-alone oncology groups, university-affiliated cancer clinics, and health system-affiliated cancer centers

For more information on how ACCESSEXPRESS works:

Custom Projects

Brings an advanced set of global and bespoke market access capabilities, frameworks, and methods to answer your specific questions across the product lifecycle.

  • Customer Segmentation

    Behavioral and attitudinal segmentation of organized customers tailored to client-specific desired outcomes

  • Patient Access and Reimbursement Requirements

    Assessment requirements and opportunities for patient access and support via Hub or other programs

  • Customer Relationship Assessment

    Measurement of relationships with your customers and identification of drivers of productive relationships

  • Opportunity and Threat Assessment

    Evaluation of the opportunities and threats presented by a specific macro-environmental or customer change and identification of strategies to ensure future success

  • Value Proposition Assessment

    Identification and testing of the optimal value proposition of a product/compound with market access stakeholders

  • Customer Programs and Resources

    Identifying the optimal programs and resources for payer access and relationship development

Featured Content

How Could Policy Changes to Protected Classes Impact Part D Access and Contracting?

(Content Updated 5/17) CMS Protected Class Rule Finalized, Slightly Loosened for Biopharma Following CMS’ 2018 proposed rule allowing for new protected class exceptions and a comment period for stakeholders through the beginning of this year, CMS has released a final rule addressing the Medicare Part D Protected Classes. The proposed rule allowed plans to restrict […]

German and United Kingdom Physicians Express Frustration with Health System Challenges

This brief by Health Strategies Insights summarizes preliminary results compiled from twelve 30-minute, one-on-one, in-depth, telephone interviews with a mix of physician specialists from the United Kingdom (U.K.) and Germany. While the physicians discussed benefits of their respective health care systems, many raised significant challenges and limitations in providing the care they believed would be […]

Contact Us

  • This field is for validation purposes and should be left unchanged.